The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation
Summary
This summary is machine-generated.Familial hypertrophic cardiomyopathy (FHC) progression involves early kinetic changes preceding structural damage. This study reveals how genetic defects in sarcomeric proteins lead to distinct early and late cardiac abnormalities in a mouse model.
Area Of Science
- Cardiovascular Biology
- Genetic Medicine
- Molecular Cardiology
Background
- Familial hypertrophic cardiomyopathy (FHC) is a genetic cardiac disease caused by sarcomeric protein mutations.
- FHC is characterized by impaired relaxation, fibrosis, and increased stiffness, but early versus late changes are unclear.
Purpose Of The Study
- To distinguish early molecular and functional abnormalities from later pathological responses in FHC.
- To investigate the temporal progression of cardiac dysfunction in a mouse model of FHC.
Main Methods
- In vivo analysis of a mouse model with an alpha-cardiac myosin heavy chain mutation (Arg403Gln).
- Utilized in situ pressure-volume relation assessments to evaluate cardiac function.
- Compared young (6 weeks) and older (20 weeks) mutant mice to track disease evolution.
Main Results
- Young FHC mice showed delayed relaxation and filling, with accelerated systolic pressure rise, despite normal morphology.
- Older FHC mice exhibited hallmarks of human FHC, including hyperdynamic contraction, increased stiffness, and outflow tract gradients.
- Diastolic and systolic kinetic changes in older mice were similar to or less pronounced than in younger mice, suggesting distinct progression pathways.
Conclusions
- Early FHC pathogenesis involves altered cardiac kinetics preceding structural changes.
- The study elucidates the temporal sequence of functional and structural alterations in FHC.
- Findings may guide therapeutic strategies targeting FHC progression and mitigating disease severity.
View abstract on PubMed